Perspective Therapeutics (CATX) Amortizatization of Intangibles (2010 - 2023)
Perspective Therapeutics (CATX) reported Amortizatization of Intangibles of $14000.0 for Q4 2023, down 17.65% on a YoY basis from $17000.0 in Q4 2022, and up 55.56% sequentially from $9000.0 in Q3 2023.
Perspective Therapeutics (CATX) Amortizatization of Intangibles (2010 - 2023) Analysis & Trends
Perspective Therapeutics (CATX) has 14 years of Amortizatization of Intangibles data on file, last reported at $14000.0 in Q4 2023.
- For the quarter ending Q4 2023, Amortizatization of Intangibles fell 17.65% year-over-year to $14000.0; the trailing twelve-month figure through Sep 2024 stood at $14000.0 (down 67.44% YoY), and the FY2023 full-year result was $40000.0, up 21.21% from the prior year.
- Amortizatization of Intangibles grew to $14000.0 in Q4 2023, from $9000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $25000.0 in Q3 2022 to a low of -$9000.0 in Q4 2021.
- A 5-year average of $10736.8 and a median of $10000.0 in 2020 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles tumbled 250.0% in 2021 and jumped 288.89% in 2022, its largest moves.
- Tracing CATX's Amortizatization of Intangibles over 5 years: stood at $13000.0 in 2019, then plunged by 53.85% to $6000.0 in 2020, then plunged by 250.0% to -$9000.0 in 2021, then jumped by 288.89% to $17000.0 in 2022, then dropped by 17.65% to $14000.0 in 2023.
- Business Quant data shows CATX's Amortizatization of Intangibles at $14000.0 in Q4 2023, $9000.0 in Q3 2023, and $8000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Perspective Therapeutics | 294.24 Mn | 294.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Sep 30, 2021 | 10,000.00 |